Andrew Powell
Director/Board Member bij ACLARIS THERAPEUTICS, INC.
Vermogen: 35 790 $ op 31-03-2024
Profiel
Andrew Kenneth William Powell currently works at Aclaris Therapeutics, Inc., as Independent Director from 2017, Cure Network Ventures, Inc., as Director from 2017, SciaDerm, Inc., as Director, and Gibson, Dunn & Crutcher LLP, as Associate.
Mr. Powell also formerly worked at Lifecore Biomedical, Inc., as Independent Director from 2020 to 2022, Synthorx, Inc., as Independent Director from 2018 to 2020, Motif Bio Plc, as Non-Executive Director in 2019, Silverback Therapeutics, Inc., as Independent Director from 2020 to 2022, Baxter International, Inc., as Vice President & Chief International Counsel, ImClone LLC, as Senior Vice President & General Counsel from 2008 to 2009, CollaGenex Pharmaceuticals, Inc., as Secretary, Executive VP & General Counsel from 2004 to 2008, InterMune, Inc., as Secretary, Executive VP & General Counsel from 2013 to 2015, Medivation LLC (California), as Secretary, Senior Vice President & General Counsel from 2015 to 2016, and Cornerstone Therapeutics, Inc., as Secretary, Executive VP & General Counsel from 2009 to 2013.
Mr. Powell received his undergraduate degree in 1979 from The University of North Carolina at Chapel Hill and graduate degree in 1985 from Stanford Law School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 04-03-2024 | 28 863 ( 0.04% ) | 35 790 $ | 31-03-2024 |
Actieve functies van Andrew Powell
| Bedrijven | Functie | Begin |
|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Director/Board Member | 25-01-2017 |
Cure Network Ventures, Inc.
 Cure Network Ventures, Inc. Pharmaceuticals: MajorHealth Technology Part of The J. David Gladstone Institutes, Cure Network Ventures, Inc. develops potential therapies. The private company is based in San Francisco, CA. | Director/Board Member | 01-02-2017 |
SciaDerm, Inc.
 SciaDerm, Inc. Pharmaceuticals: MajorHealth Technology SciaDerm, Inc. develops novel treatment drugs for treating psoriasis. It provides dermatology products. The company was founded by Klaus P. J. Theobald and is headquartered in Paoli, PA. | Director/Board Member | - |
Gibson, Dunn & Crutcher LLP
 Gibson, Dunn & Crutcher LLP Miscellaneous Commercial ServicesCommercial Services Gibson, Dunn & Crutcher LLP provides legal services. It offers services to labor, employment, entertainment and media law, toxic torts and other environmental services. The company was founded in 1890 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | - |
Eerdere bekende functies van Andrew Powell
| Bedrijven | Functie | Einde |
|---|---|---|
| LIFECORE BIOMEDICAL, INC. | Chairman | 14-10-2020 |
| ARS PHARMACEUTICALS, INC. | Director/Board Member | 10-06-2022 |
| SYNTHORX, INC. | Director/Board Member | 23-01-2020 |
| MOTIF BIO PLC | Director/Board Member | 15-11-2019 |
| MEDIVATION INC | General Counsel | 01-11-2016 |
Opleiding van Andrew Powell
| The University of North Carolina at Chapel Hill | Undergraduate Degree |
| Stanford Law School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| LIFECORE BIOMEDICAL, INC. | Health Technology |
| ACLARIS THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 11 |
|---|---|
Gibson, Dunn & Crutcher LLP
Gibson, Dunn & Crutcher LLP Miscellaneous Commercial ServicesCommercial Services Gibson, Dunn & Crutcher LLP provides legal services. It offers services to labor, employment, entertainment and media law, toxic torts and other environmental services. The company was founded in 1890 and is headquartered in Los Angeles, CA. | Commercial Services |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
CollaGenex Pharmaceuticals, Inc.
 CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Cornerstone Therapeutics, Inc.
 Cornerstone Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cornerstone Therapeutics, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for the hospital, rare disease and adjacent specialty care settings. It acquires, develops and commercializes prescription pharmaceutical drugs. The company was founded on October 31, 2008 and is headquartered in Cary, NC. | Health Technology |
Synthorx, Inc.
 Synthorx, Inc. BiotechnologyHealth Technology Synthorx, Inc. focuses on prolonging and improving lives of cancer and autoimmune disorder patients. Its product pipeline is comprised of THOR-707, IL-2 Synthorin, IL-10 Synthorin, and IL-15 Synthorin. The company was founded by Floyd E. Romesberg and Court R. Turner in 2014 and is headquartered in La Jolla, CA. | Health Technology |
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company was founded by Peter A. Thompson January 4, 2016 and is headquartered in Seattle, WA. | Health Technology |
Cure Network Ventures, Inc.
Cure Network Ventures, Inc. Pharmaceuticals: MajorHealth Technology Part of The J. David Gladstone Institutes, Cure Network Ventures, Inc. develops potential therapies. The private company is based in San Francisco, CA. | Health Technology |
SciaDerm, Inc.
SciaDerm, Inc. Pharmaceuticals: MajorHealth Technology SciaDerm, Inc. develops novel treatment drugs for treating psoriasis. It provides dermatology products. The company was founded by Klaus P. J. Theobald and is headquartered in Paoli, PA. | Health Technology |
Motif Bio Plc
 Motif Bio Plc Pharmaceuticals: MajorHealth Technology Motif Bio Plc is a clinical stage biopharmaceutical company, which engages in the development and commercialization of pharmaceutical formulations. The company focuses on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It offers Iclaprim, a novel diaminopyrimidine antibiotic that inhibits an essential bacterial enzyme called dihydrofolate reductase. The company was founded by Jonathan E. Gold on November 20, 2014 and is headquartered in Princeton, NJ. | Health Technology |
